Antiretroviral therapy coverage in IDA blend
IDA blend: Antiretroviral therapy coverage was 81.2% in 2024. ◆ Volatile
Antiretroviral therapy coverage in IDA blend, 2000–2024
Source: UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS). Measured in % of people living with HIV.
Analysis
IDA blend recorded 81.2% for antiretroviral therapy coverage in 2024. That is the highest value across all 25 years on record.
That represents a change of up 3.4% on the previous year and up 93.4% over ten years.
Over the whole period, antiretroviral therapy coverage in IDA blend peaked at 81.2% in 2024 and was at its lowest, 0.6%, in 2000.
That places IDA blend 13th out of 23 groups with data for 2024, putting it in the middle of the range.
The series is highly variable year to year, so single readings are best treated with caution.
Antiretroviral therapy coverage in IDA blend, year by year
| Year | % of people living with HIV | Change |
|---|---|---|
| 2000 | 0.6% | — |
| 2001 | 0.6% | +2.2% |
| 2002 | 0.8% | +42.2% |
| 2003 | 0.8% | +3.7% |
| 2004 | 2.2% | +165.5% |
| 2005 | 3.4% | +52.1% |
| 2006 | 6.4% | +88.1% |
| 2007 | 8.6% | +33.8% |
| 2008 | 12.8% | +49.5% |
| 2009 | 17.3% | +35.3% |
| 2010 | 22.3% | +28.9% |
| 2011 | 27.1% | +21.5% |
| 2012 | 32.1% | +18.3% |
| 2013 | 36.7% | +14.5% |
| 2014 | 42.0% | +14.3% |
| 2015 | 47.9% | +14.0% |
| 2016 | 54.3% | +13.4% |
| 2017 | 60.1% | +10.8% |
| 2018 | 61.7% | +2.7% |
| 2019 | 65.4% | +6.0% |
| 2020 | 68.3% | +4.4% |
| 2021 | 72.2% | +5.7% |
| 2022 | 75.6% | +4.7% |
| 2023 | 78.6% | +3.9% |
| 2024 | 81.2% | +3.4% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 5.3% | 0.6% | 17.3% | 10 |
| 2010s | 45.0% | 22.3% | 65.4% | 10 |
| 2020s | 75.2% | 68.3% | 81.2% | 5 |
Countries ranked near IDA blend
More health data for IDA blend
- Population ages 65 and above, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 0-14, male 38.2% (2025)
- Population ages 65 and above, total, annual growth rate 3.47 % change on previous year (2025)
- Population ages 65 and above, male, per capita 0.0171 units per person (2025)
- Population ages 65 and above, male, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 0-14, male 132.88 million (2025)
- Population ages 0-14, female 37.6% (2025)
- Population ages 65 and above, male, annual growth rate 3.33 % change on previous year (2025)
- Population ages 65 and above, female, per capita 0.0201 units per person (2025)
- Population ages 65 and above 3.7% (2025)
Frequently asked questions
- What is antiretroviral therapy coverage in IDA blend?
- Antiretroviral therapy coverage in IDA blend was 81.2% in 2024, according to UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS).
- What is the highest antiretroviral therapy coverage recorded in IDA blend?
- The highest recorded value was 81.2% in 2024.
- What is the lowest antiretroviral therapy coverage recorded in IDA blend?
- The lowest recorded value was 0.6% in 2000.
- How does IDA blend rank for antiretroviral therapy coverage?
- IDA blend ranks 13th out of 23 groups with data for 2024.
- Is antiretroviral therapy coverage rising or falling in IDA blend?
- Over the last ten years it is up 93.4%. The long-run trend across the full record is volatile.
- Where does this IDA blend data come from?
- The figures come from UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS), published as part of Antiretroviral therapy coverage (% of people living with HIV). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 25 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
Antiretroviral therapy coverage indicates the percentage of all people living with HIV who are receiving antiretroviral therapy.